adjuvant immunotherapy with polyadenylic-polyuridylic acid ( polya.polyu ) was tested in a randomised trial on 300 patients with operable breast cancer , all of whom were treated by surgery with or without radiotherapy .
C0032402
polyadenylic-polyuridylic acid
C0032400
polya